Verapamil D7 Hydrochloride

Verapamil D7 Hydrochloride is a deuterated form of Verapamil Hydrochloride, which is a calcium channel blocker used to treat hypertension, angina pectoris, and arrhythmias. The deuterium substitution in Verapamil D7 Hydrochloride allows for more precise analysis in pharmacokinetics and drug metabolism studies. The chemical formula of Verapamil D7 Hydrochloride is C27H36D7ClN2O4, with a molecular weight of 498.11 g/mol. It is a white to off-white powder that is soluble in water and methanol. The mechanism of action of Verapamil D7 Hydrochloride involves blocking the entry of calcium ions into smooth muscle cells and cardiac muscle cells, leading to relaxation of the blood vessels and decreased cardiac contractility. It also has antiarrhythmic properties by slowing down the electrical conduction in the heart. The recommended dosage of Verapamil D7 Hydrochloride varies depending on the condition being treated and the patient's age and medical history. It is usually administered orally, and the onset of action is within 1-2 hours. Verapamil D7 Hydrochloride may interact with other medications, and caution should be taken in patients with liver or kidney disease. Common side effects include dizziness, headache, constipation, and nausea. In conclusion, Verapamil D7 Hydrochloride is a useful tool in pharmacokinetics and drug metabolism studies, allowing for more precise analysis of Verapamil Hydrochloride's effects on the body.